Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Idcases
|
January 17, 2022
Resolution of <i>Pediococcus acidilactici</i> bacteremia without antibiotic therapy in a 16-year-old adolescent with leukemia receiving maintenance chemotherapy
Jun Tachikawa, Yuta Aizawa, Ryohei Izumita, et al.
Clinical & Translational Immunology
|
July 17, 2020
Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity
Yasushi Kasahara, Chansu Shin, Nobuhiro Kubo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 29, 2025
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodies
Nobuhiro Kubo, Minori Baba, Chansu Shin, et al.
Frontiers in Pediatrics
|
October 12, 2020
Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia
Yasushi Kasahara, Masaru Imamura, Chansu Shin, et al.
Translational Oncology
|
September 23, 2021
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma
Yudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, et al.
Molecular Medicine Reports
|
July 11, 2025
Chimeric PD‑1 receptor redirects primary T cells against childhood solid tumors but not to PD‑1 ligand‑positive CD80‑coexpressing cells
Chansu Shin, Masaru Imamura, Yasushi Kasahara, et al.
Vaccine
|
March 17, 2026
Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan
Yuta Aizawa, Yugo Shobugawa, Jun Tachikawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 8, 2026
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept study
Tomohiro Miyazaki, Yudai Murayama, Naoki Oike, et al.
Translational Oncology
|
August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma
Yudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 10, 2021
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
Sakiko Harada, Miki Ando, Jun Ando, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Idcases
|
January 17, 2022
Resolution of <i>Pediococcus acidilactici</i> bacteremia without antibiotic therapy in a 16-year-old adolescent with leukemia receiving maintenance chemotherapy
Jun Tachikawa, Yuta Aizawa, Ryohei Izumita, et al.
Clinical & Translational Immunology
|
July 17, 2020
Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity
Yasushi Kasahara, Chansu Shin, Nobuhiro Kubo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 29, 2025
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodies
Nobuhiro Kubo, Minori Baba, Chansu Shin, et al.
Frontiers in Pediatrics
|
October 12, 2020
Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia
Yasushi Kasahara, Masaru Imamura, Chansu Shin, et al.
Translational Oncology
|
September 23, 2021
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma
Yudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, et al.
Molecular Medicine Reports
|
July 11, 2025
Chimeric PD‑1 receptor redirects primary T cells against childhood solid tumors but not to PD‑1 ligand‑positive CD80‑coexpressing cells
Chansu Shin, Masaru Imamura, Yasushi Kasahara, et al.
Vaccine
|
March 17, 2026
Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan
Yuta Aizawa, Yugo Shobugawa, Jun Tachikawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 8, 2026
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept study
Tomohiro Miyazaki, Yudai Murayama, Naoki Oike, et al.
Translational Oncology
|
August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma
Yudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 10, 2021
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
Sakiko Harada, Miki Ando, Jun Ando, et al.
Page
of 1